Susquehanna International Group, LLP Mirati Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $9.04 Million - $13.4 Million	215,300 Added 523.84%	256,400 $15.1 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $522,640 - $852,580	-18,800 Reduced 31.39%	41,100 $1.79 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $751,504 - $1.03 Million	20,800 Added 53.2%	59,900 $2.16 Million
Q1 2023 May 16, 2023	SELL	$36.54 - $54.26 $2.63 Million - $3.91 Million	-72,100 Reduced 64.84%	39,100 $1.45 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $660,320 - $1.58 Million	-16,000 Reduced 12.58%	111,200 $5.04 Million

Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $4 Million - $5.83 Million	67,200 Added 112.0%	127,200 $8.88 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $935,923 - $2.12 Million	23,900 Added 66.2%	60,000 $4.03 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $1.09 Million - $2.17 Million	-14,400 Reduced 28.51%	36,100 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $1 Million - $1.45 Million	7,600 Added 17.72%	50,500 $7.41 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $1.45 Million - $1.95 Million	11,000 Added 34.48%	42,900 $7.59 Million
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $9.49 Million - $11.8 Million	-65,900 Reduced 67.38%	31,900 $5.15 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $4.02 Million - $5.61 Million	25,300 Added 34.9%	97,800 $16.8 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $113,435 - $168,189	-700 Reduced 0.96%	72,500 $15.9 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $351,106 - $518,537	-3,100 Reduced 4.06%	73,200 $12.2 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $28,804 - $48,156	400 Added 0.53%	76,300 $8.71 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $2.8 Million - $4.66 Million	-40,100 Reduced 34.57%	75,900 $5.83 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $8.92 Million - $16.2 Million	-126,100 Reduced 52.09%	116,000 $14.9 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $475,251 - $668,560	-6,100 Reduced 2.46%	242,100 $18.9 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $12.5 Million - $21.9 Million	209,400 Added 539.69%	248,200 $25.6 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $200,790 - $363,170	4,600 Added 13.45%	38,800 $2.84 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $2.65 Million - $3.93 Million	-82,900 Reduced 70.79%	34,200 $1.45 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $2.84 Million - $3.79 Million	60,400 Added 106.53%	117,100 $5.52 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $1.01 Million - $2.03 Million	38,800 Added 216.76%	56,700 $2.8 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $130,720 - $265,620	7,600 Added 73.79%	17,900 $550,000
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $640,090 - $961,400	-50,600 Reduced 83.09%	10,300 $188,000
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $286,230 - $712,530	60,900	60,900 $713,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account